Skip to main content
. 2017 Jun 17;216(4):436–446. doi: 10.1093/infdis/jix291

Table 1.

Patient Demographics

Clinical Variables Control Mothers
(n = 15)
HIV-Infected Mothers
(n = 12)
P Value
Median (75% CI) Median (75% CI)
Age, y 32.6 (30.7–33.2) 28.5 (28.2–32.4) .50a
Prepregnancy weight, kg 64.5b (62.7–66.9) 68.5 (65.7–74.2) .41a
Prepregnancy BMI 22.04b (22.3–24.1) 23.67 (22.6–26.1) .79a
Total triglyceridesc, mmol/L 1.80d (1.5–2.1)
Total cholesterolc, mmol/L 5d (4.6–5.4)
Glucosec, mmol/L 4.30d (4.2–4.7)
Ethnicity (white/black/South Asian), No. 9/4/2 3/9/0 .03e
Gestational diabetes (yes/no), No. 0/15 0/12
Viral load, copies/mL Trimester 1 528.5 (1269–9084)
Trimester 2 50 (47.81–281)
Trimester 3f <50
CD4 count, × 106 cells/L Trimester 1 455 (465.5–594.5)
Trimester 2 520 (511.4–650.6)
Trimester 3 700 (616.5–792.5)
Control Infants
(n = 15)
cART/HIV-1–Exposed Infants (n = 12)
Gestation period, wk 40 (37.63–39.97) 39.25 (38.74–39.82) .57a
Birth weight, g 3380 (3128–3494) 3085 (3009–3472) .34a
Apgar score (5 min) 10 (9.5–9.9) 10 (9.1–9.9) .44a
Mode of delivery (vaginal/cesarean), No. 14/1 8/4 .14e
Gender (male/female), No. 8/7 7/5 .55e

Abbreviations: BMI, body mass index; CI, confidence interval.

aMann–Whitney U test.

bOne mising value.

cMeasured at the end of the second trimester.

dTwo missing values.

eFisher exact test.

fAll mothers were below the limit of detection.